LinkedIn Profile

Access Hutchison MediPharma historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:hutchisonmedipharma 566732 May 29th, 2019 12:00AM Hutchison MediPharma 1.2K 183.00 Open Pharmaceuticals May 28th, 2019 08:48PM May 28th, 2019 08:48PM Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of over 400 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia, China and Korea. Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly and Nestlé Health Science in oncology and inflammation research & development. HMP is a subsidiary of Chi-Med (Hutchison China MediTech, www.chi-med.com). Open pharmaceuticals, biotechnology, pharma, biotech, Shanghai, China, research, development, drugs, botanicals, targeted therapies, nce, cancer, oncology, autoimmune disease, inflammation, IBD, lymphoma, tumors, kinase inhibitors Open Building 4, 720 Cailun Road,, Zhangjiang Hi-Tech Park Shanghai CN 201203 Hutchison MediPharma Health Care Health Care Equipment & Services
private:hutchisonmedipharma 566732 Mar 15th, 2018 12:00AM Hutchison MediPharma 908 149.00 Open Pharmaceuticals Mar 14th, 2018 08:21PM Mar 14th, 2018 08:21PM Open Hutchison MediPharma Health Care Health Care Equipment & Services
private:hutchisonmedipharma 566732 Feb 17th, 2018 12:00AM Hutchison MediPharma 857 135.00 Open Pharmaceuticals Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of around 300 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia and China. Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly, Janssen and Nestlé Health Science in oncology and inflammation research & development. HMP is a subsidiary of Chi-Med (Hutchison China MediTech). Hutchison MediPharma Health Care Health Care Equipment & Services
private:hutchisonmedipharma 566732 Feb 16th, 2018 12:00AM Hutchison MediPharma 857 135.00 Open Pharmaceuticals Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of around 300 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia and China. Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly, Janssen and Nestlé Health Science in oncology and inflammation research & development. HMP is a subsidiary of Chi-Med (Hutchison China MediTech). Hutchison MediPharma Health Care Health Care Equipment & Services
private:hutchisonmedipharma 566732 Feb 15th, 2018 12:00AM Hutchison MediPharma 857 135.00 Open Pharmaceuticals Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of around 300 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia and China. Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly, Janssen and Nestlé Health Science in oncology and inflammation research & development. HMP is a subsidiary of Chi-Med (Hutchison China MediTech). Hutchison MediPharma Health Care Health Care Equipment & Services
private:hutchisonmedipharma 566732 Feb 14th, 2018 12:00AM Hutchison MediPharma 857 135.00 Open Pharmaceuticals Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of around 300 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia and China. Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly, Janssen and Nestlé Health Science in oncology and inflammation research & development. HMP is a subsidiary of Chi-Med (Hutchison China MediTech). Hutchison MediPharma Health Care Health Care Equipment & Services
private:hutchisonmedipharma 566732 Feb 13th, 2018 12:00AM Hutchison MediPharma 857 135.00 Open Pharmaceuticals Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of around 300 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia and China. Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly, Janssen and Nestlé Health Science in oncology and inflammation research & development. HMP is a subsidiary of Chi-Med (Hutchison China MediTech). Hutchison MediPharma Health Care Health Care Equipment & Services
private:hutchisonmedipharma 566732 Feb 12th, 2018 12:00AM Hutchison MediPharma 857 135.00 Open Pharmaceuticals Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of around 300 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia and China. Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly, Janssen and Nestlé Health Science in oncology and inflammation research & development. HMP is a subsidiary of Chi-Med (Hutchison China MediTech). Hutchison MediPharma Health Care Health Care Equipment & Services
private:hutchisonmedipharma 566732 Feb 11th, 2018 12:00AM Hutchison MediPharma 857 135.00 Open Pharmaceuticals Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of around 300 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia and China. Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly, Janssen and Nestlé Health Science in oncology and inflammation research & development. HMP is a subsidiary of Chi-Med (Hutchison China MediTech). Hutchison MediPharma Health Care Health Care Equipment & Services
private:hutchisonmedipharma 566732 Feb 10th, 2018 12:00AM Hutchison MediPharma 857 135.00 Open Pharmaceuticals Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of around 300 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia and China. Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly, Janssen and Nestlé Health Science in oncology and inflammation research & development. HMP is a subsidiary of Chi-Med (Hutchison China MediTech). Hutchison MediPharma Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.